HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

Abstract
The IL-10-like cytokine IL-22 is produced by activated T cells. In this study, we analyzed the role of this cytokine system in hepatic cells. Expression studies were performed by RT-PCR and quantitative PCR. Signal transduction was analyzed by Western blot experiments and ELISA. Cell proliferation was measured by MTS and [(3)H]thymidine incorporation assays. Hepatocyte regeneration was studied in in vitro restitution assays. Binding of IL-22 to its receptor complex expressed on human hepatic cells and primary human hepatocytes resulted in the activation of MAPKs, Akt, and STAT proteins. IL-22 stimulated cell proliferation and migration, which were both significantly inhibited by the phosphatidylinositol 3-kinase inhibitor wortmannin. IL-22 increased the mRNA expression of suppressor of cytokine signaling (SOCS)-3 and the proinflammatory cytokines IL-6, IL-8, and TNF-alpha. SOCS-1/3 overexpression abrogated IL-22-induced STAT activation and decreased IL-22-mediated liver cell regeneration. Hepatic IL-22 mRNA expression was detectable in different forms of human hepatitis, and hepatic IL-22 mRNA levels were increased in murine T cell-mediated hepatitis in vivo following cytomegalovirus infection, whereas no significant differences were seen in an in vivo model of ischemia-reperfusion injury. In conclusion, IL-22 promotes liver cell regeneration by increasing hepatic cell proliferation and hepatocyte migration through the activation of Akt and STAT signaling, which is abrogated by SOCS-1/3 overexpression.
AuthorsStephan Brand, Julia Dambacher, Florian Beigel, Kathrin Zitzmann, Malte H J Heeg, Thomas S Weiss, Thomas Prüfer, Torsten Olszak, Christian J Steib, Martin Storr, Burkhard Göke, Helmut Diepolder, Manfred Bilzer, Wolfgang E Thasler, Christoph J Auernhammer
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 292 Issue 4 Pg. G1019-28 (Apr 2007) ISSN: 0193-1857 [Print] United States
PMID17204547 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Inflammation Mediators
  • Interleukins
  • RNA, Messenger
  • Receptors, Interleukin
  • SOCS1 protein, human
  • SOCS3 protein, human
  • STAT Transcription Factors
  • Suppressor of Cytokine Signaling 1 Protein
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins
  • interleukin-22 receptor
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Animals
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Hepatectomy
  • Hepatitis (metabolism)
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Inflammation Mediators (metabolism)
  • Interleukins (metabolism, pharmacology)
  • Liver (cytology, metabolism, surgery)
  • Liver Regeneration
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred C57BL
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA, Messenger (metabolism)
  • Receptors, Interleukin (genetics, metabolism)
  • STAT Transcription Factors (metabolism)
  • Signal Transduction (drug effects)
  • Suppressor of Cytokine Signaling 1 Protein
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins (genetics, metabolism)
  • T-Lymphocytes (metabolism)
  • Time Factors
  • Transfection
  • Up-Regulation
  • Interleukin-22

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: